Annual Cash & Cash Equivalents
$4.58B$291.85M-5.99%
Summary
- Current Value
- As of today, GSK annual cash & cash equivalents is $4.58B, down -5.99% on
- Historical Performance
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years, down -47.39% over the past 5 years
- All-Time High Comparison
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on
- 3-Year Low Comparison
- GSK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GSK annual cash & cash equivalents is higher than 97.43% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% | |
| Quarterly Cash & Cash Equivalents | $3.93B | -11.6% | -51.8% | -16.9% | -55.6% | |
| Price | $50.33 | +6.9% | +44.7% | +13.5% | +11.1% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Total Liabilities | $60.75B | +4.6% | +0.9% | -25.5% | +19.4% | |
| Annual Working Capital | -$5.22B | +11.3% | -112.6% | -100.9% | -202.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.48B | N/A | -51.6% |
| 5Y | $9.48B | -51.6% | |
| All | $11.21B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.58B | at low | |
| 5Y | $4.58B | at low | |
| All | $37.03M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
- What is the current annual cash & cash equivalents of GSK?
- As of today, GSK annual cash & cash equivalents is $4.58B
- What is 1-year change in GSK annual cash & cash equivalents?
- GSK annual cash & cash equivalents is down -5.99% year-over-year
- What is 3-year change in GSK annual cash & cash equivalents?
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years
- How far is GSK annual cash & cash equivalents from its all-time high?
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on December 31, 2009
- How does GSK annual cash & cash equivalents rank versus sector peers?
- GSK annual cash & cash equivalents is higher than 97.43% of companies in Healthcare sector
- When is GSK next annual earnings release?
- The next annual earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$3.93B$187.57M-4.55%
Summary
- Current Value
- As of today, GSK quarterly cash & cash equivalents is $3.93B, down -4.55% on
- Historical Performance
- GSK quarterly cash & cash equivalents is down -11.59% year-over-year, down -51.76% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash & cash equivalents is currently -74.67% below its historical high of $15.54B set on
- 3-Year Low Comparison
- GSK quarterly cash & cash equivalents is +4.35% above its 3-year low of $3.77B reached on
- Sector Comparison
- GSK quarterly cash & cash equivalents is higher than 96.86% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $3.93B | -4.5% | -11.6% | -51.8% | -16.9% | |
| Annual Cash & Cash Equivalents | $4.58B | – | -6.0% | -51.6% | -47.4% | |
| Price | $50.33 | -3.5% | +6.9% | +44.7% | +13.5% | |
| Quarterly Current Assets | $23.77B | +2.0% | -1.0% | -8.3% | -3.4% | |
| Quarterly Total Liabilities | $70.86B | +19.8% | +15.4% | +20.3% | -7.7% | |
| Quarterly Working Capital | -$3.75B | +28.9% | +20.2% | -167.4% | +33.1% | |
| Quarterly Net Income | $2.29B | +208.4% | -20.8% | +17.9% | +75.6% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.58B | -14.1% | |
| 3Y | $8.16B | N/A | -51.8% |
| 5Y | $10.37B | -62.1% | |
| All | $15.54B | -74.7% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.93B | at low | |
| 3Y | $3.77B | +4.3% | |
| 5Y | $3.77B | +4.3% | |
| All | $37.03M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
- What is the current quarterly cash & cash equivalents of GSK?
- As of today, GSK quarterly cash & cash equivalents is $3.93B
- What is GSK quarterly cash & cash equivalents most recent change?
- GSK quarterly cash & cash equivalents was down -4.55% on September 30, 2026
- What is 1-year change in GSK quarterly cash & cash equivalents?
- GSK quarterly cash & cash equivalents is down -11.59% year-over-year
- How far is GSK quarterly cash & cash equivalents from its all-time high?
- GSK quarterly cash & cash equivalents is currently -74.67% below its historical high of $15.54B set on March 31, 2015
- How does GSK quarterly cash & cash equivalents rank versus sector peers?
- GSK quarterly cash & cash equivalents is higher than 96.86% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk